1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Pathways for Regulatory Innovation and Strategic Modernization" is currently closed and not accepting applications.
Pathways for Regulatory Innovation and Strategic Modernization is sponsored by Department of Health and Human Services (HHS). This program aims to support innovative approaches in regulatory science, food safety, and nutrition to enhance public health.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Pathways for Regulatory Innovation and Strategic Modernization (PRISM) Pathways for Regulatory Innovation and Strategic Modernization (PRISM) Agency: Food and Drug Administration Assistance Listings: 93. 103 -- Food and Drug Administration Research Last Updated: March 31, 2026 View version history on Grants.
gov The Pathways for Regulatory Innovation and Strategic Modernization (PRISM) cooperative agreement is intended to advance public health by strengthening the scientific, collaborative, and operational foundations needed to modernize regulatory oversight in an increasingly complex and rapidly evolving public health landscape.
As innovation in medical products, diagnostics, foods, and digital health accelerates, our nation must continuously adapt its regulatory science approaches to ensure timely access to safe, effective, and high-quality products for the American public.
PRISM is designed to support this modernization by enabling forward-looking, non-regulatory collaborations that align with the Commissioner’s strategic priorities and the Administration’s broader public health goals.
PRISM provides a flexible, scalable approach to patient, consumer, industry, academia, and healthcare workforce engagement to generate applied scientific knowledge, tools, and approaches that enhance regulatory predictability, efficiency, and transparency.
By leveraging independent expertise and real-world insights, PRISM bridges gaps between innovation and regulation to optimize uptake of emerging technologies, evolving consumer needs, and new sources of evidence such as real-world data and real-world evidence. Only the following applicant is eligible to apply for this single source funding: Reagan-Udall Foundation for the Food and Drug Administration.
Grantor contact information Grants Management Specialist patrick. johnson@fda. hhs.
gov File name Description Last updated RFA-FD-26-007_Pathways_for_Regulatory_Innovation_and_Strategic_Modernization_. pdf Notice of Funding Opportunity Announcement (NOFO) Mar 31, 2026 07:07 PM UTC Link to additional information Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity :
According to the current listing, eligibility includes: State and local health departments, universities, and nonprofit organizations. Confirm the full requirements in the official notice before applying.
The published deadline was April 30, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Pathways for Regulatory Innovation and Strategic Modernization is funded by Department of Health and Human Services (HHS). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Diaper Distribution Demonstration Research Pilot (DDDRP) is sponsored by Department of Health and Human Services (HHS). A program designed to evaluate the implementation and impact of diaper distribution programs, aiming to deliver a continuous, sufficient supply of diapers to caregivers and children with low incomes, and to improve these families' overall health and economic well-being.
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) is sponsored by Department of Health and Human Services (HHS). This is a broad STTR grant opportunity from HHS, which includes NIH. It supports small businesses in developing promising technologies and products through cooperative research with a non-profit research institution, aligning with the NIH mission to improve health. Research on diabetic retinopathy could be proposed under this parent announcement.
The HHS Grants Policy Statement that took effect October 1, 2025 raised the micro-purchase threshold to $50,000, the single audit threshold to $1 million, and the de minimis indirect cost rate to 15 percent — quietly rewriting the operational rules for tens of billions of dollars in annual awards. Combined with full 2 CFR Parts 200 and 300 adoption and new MAHA-aligned program priorities, it is the biggest compliance shift for health grantees since Uniform Guidance arrived in 2013.
Read articleThe STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read articleHHS launched the STREETS Initiative and SAMHSA announced $69M in mental health grants as part of the Great American Recovery. A deep analysis of eligibility, strategy, and what organizations should apply.
Read article